The efficiency of topical therapy and prevention of inflammatory diseases of the pharynx
https://doi.org/10.21518/2079-701X-2018-8-29-33
Abstract
Today, one of the most frequent causes for visiting paediatricians, general practitioners, ENT specialists are infectious inflammatory diseases of the pharynx [1]. Acute pharyngitis is a common manifestation of various acute respiratory viral and bacterial infections [2]. The drugs to be used for the local treatment of pharyngitis should meet the following requirements: have a broad spectrum of antibacterial activity, no toxic or irritating effects on the mucous membrane, low absorption rate and low allergenicity.
About the Authors
S. V. Ryazantsev
Saint-Petersburg Research Institute of Ear, Throat, Nose and Speech of the Ministry of Health of Russia
Russian Federation
MD, Prof.
Russian Federation
MD, Prof.
P. A. Shamkina
Saint-Petersburg Research Institute of Ear, Throat, Nose and Speech of the Ministry of Health of Russia
Russian Federation
Russian Federation
References
1. Subbotina MV. Sore throat: possible causes, diagnosis and treatment. Lechashchiy Vrach, 2010, 9: 36.
2. Polunina TA, Vishneva EA. Pharyngitis in children. Pediatricheskaya Farmakologiya, 2011, 8 (5): 106-108.
3. Ryabova MA. Sore throat: is it always an upper respiratory tract disease? Spravochnik Poliklinicheskogo Vracha, 2010, 1: 32-37.
4. Ryazantsev SV. Topical anti-inflammatory therapy for pharyngeal diseases. Doctor.Ru, 2010, 57 (6): 22-26.
5. Ryazantsev SV. Etio patho-genetic therapy of acute pharyngitis: methodological guidelines. St. Petersburg, 2007. 40 p.
6. Lopatin AS. Treatment of acute and chronic pharyngitis. RMJ, 2001, 9 (16): 765-769.
7. Abaturov AE, Gerasimenko ON, Vysochina IL, Krivusha EL, Ermolaeva OA, Belyaeva ТV. Local therapy of acute pharyngitis in children. Zdorovie Rebenka, 2014, 52 (1): 64-68.
8. Sereda EV. Modern principles of anti-inflammatory therapy for chronic inflammatory diseases in children. Voprosy Sovremennoy Pediatrii, 2002, 1 (2): 35-36.
9. Simbirtsev AS. Cytokines are a new regulation system of the defensive mechanisms in the body. Tsitokiny i Vospalenie, 2002, 1: 9-16.
10. Steele C, Fidel PL. Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infec. Immun., 2002, 70(2): 577-583.
11. Soldatsky YuL. Symptomatic treatment of infectious inflammatory diseases of the pharynx. Lechashhiy Vrach, 2014, 10.
12. Bolbot YuK. Topical therapy of acute pharyngitis in children. Zdorovye Rebenka, 2015, 60 (1): 123-128.
13. Kryukov AI, Sedinkin AA. Materials of the Russian Conference of Otolaryngologists. M., 2002: 362-363.
14. Chernyshova OE. Rational approach to treatment of acute tonsillopharyngitis in children. Aktualnaya Infektologiya, 2016, 13 (4): 35-42.
15. Soldatsky YuL, Onufrieva EK, Gasparyan SF, Schepin NV, Steklov AM. The choice of optimal drug for the local treatment of pharyngitis in children. Zdorovye Rebenka, 2014, 52 (1): 105-109.
16. Molochek YuA. Etiotropic and pathogenetic treatment of inflammatory diseases in otorhinolaryngology. Novosti Meditsiny i Farmatsii, 2014, 7-8: 14-17.
17. Quane PA, Graham GG, Ziegler JB. Pharmacology of benzydamine. Inflammopharmacology, 1998, 6(2): 95-107.
18. Wethington JF. Double-blind study of benzydamine hydrochloride, a new treatment for sore throat. Clin. Ther., 1985, 7(5): 641-646.
19. Riboldi E, Frascaroli G, Transidico P, Luini W, Bernasconi S, Mancini F. Benzydamine inhibits monocyte migration and MAPK activation induced by chemotactic agonists. Br. J. Pharmacol., 2003, 140(2): 377-383.
20. Mangano G et al. Benzydamine Local Anestetic Activity And Batrachotoxin Binding Sites. Italian Society of Pharmacology, 2003.
21. Tarasova GD. New prospects for Tantoum Verde in the treatment of chronic tonsillitis. Farmateka, 2007, 17: 75-79.
22. Goldstein EV. Tantum Verde is an effective drug for influencing the inflammatory processes in the oral cavity. In-t Stomatologii, 2004, 24: 42-43.
23. Pina-Vaz C, Rodrigues AG, Sansonetty F, Martinez-De-Oliveira J, Fonseca AF, Mårdh PA. Antifung al activity of local anesthetics against Candida species. Infect. Dis. Obstet. Gynecol., 2000, 8(3): 124-137.
24. Morozova SV, Mityuk AM. Principles for differential diagnosis and topical therapy of acute inflammatory diseases of the pharynx. RMJ, 2011, 8: 525-530.
25. Savlevich EL, Doroshchenko NE, Slavinskaya IS, Farikov SE. Important nuances of the inflammatory process in the oropharynx and the choice of tactics for optimal treatment. Medicinskiy Sovet, 2017, 16: 48-54.
26. Kuriyama A, Aga M, Maeda H. Topical benzydamine hydrochloride for prevention of postoperative sore throat in adults undergoing tracheal intubation for elective surgery: a systematic review and meta-analysis. Anaesthesia, 2018, 73(3): 1-12.
27. Sheibani KM, Mafi AR, Moghaddam S, Taslimi F, Amiran A, Ameri A. Efficacy of benzydamine oral rinse in prevention and management of radiation-induced oral mucositis: A double-blind placebo-controlled randomized clinical trial. Asia-Pac. J. Clin. Oncol., 2015, 11(1): 22-27.
28. Rastogi M, Khurana R, Revannasiddaiah S, Jaiswal I, Nanda SS, Gupta P. Role of benzydamine hydrochloride in the prevention of oral mucositis in head and neck cancer patients treated with radiotherapy (>50 Gy) with or without chemotherapy. Support Care Cancer, 2017, 25(5): 1439-1443.
29. Denisenko RYu. Experience in using Tantum Verde in the post-operative treatment of patients after tonsillectomy. Novosti Meditsiny i Farmatsii, 2013, 471 (17): 9-10.
Review
For citations:
Ryazantsev SV, Shamkina PA. The efficiency of topical therapy and prevention of inflammatory diseases of the pharynx. Meditsinskiy sovet = Medical Council. 2018;(8):29-33. (In Russ.) https://doi.org/10.21518/2079-701X-2018-8-29-33
Views:
744
Email this article 